Evidence map›Paper›PMID 39730002›Full record

ArticleCell host & microbe2025

Phocaeicola vulgatus shapes the long-term growth dynamics and evolutionary adaptations of Clostridioides difficile.

Jordy Evan Sulaiman, Jaron Thompson, Pak Lun Kevin Cheung, Yili Qian, Jericha Mill, Isabella James, Hanhyeok Im, Eugenio I Vivas, Judith Simcox, Ophelia S Venturelli

Abstract read
In one paragraph

Article in Cell host & microbe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Proteomic study ofFrontiers in microbiology · 2025
    Article
  9. Human microbiota-associated animal models: a review.Frontiers in cellular and infection microbiology · 2025
    Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jordy Evan SulaimanDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
Jaron ThompsonDepartment of Chemical & Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Pak Lun Kevin CheungDepartment of Electrical and Computer Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Yili QianDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
Jericha MillDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
Isabella JamesIntegrated Program in Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
Hanhyeok ImDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Eugenio I VivasDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA; Gnotobiotic Animal Core Facility, University of Wisconsin-Madison, Madison, WI, USA.
Judith SimcoxHoward Hughes Medical Institute, Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
Ophelia S VenturelliDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA; Department of Chemical & Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA; Department of Biomedical Engineering, Duke University, Durham, NC, USA; Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: ophelia.venturelli@duke.edu.

Funding

Elucidating the molecular and ecological design principles of stability and assembly of the human gut microbiotaR35GM124774 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Ophelia Venturelli · 2017 to 2026
$2.9M
Discovery and characterization of a novel acylcarnitine transporter in brown adipocytesR01DK133479 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Judith Anne Simcox · 2022 to 2026
$1.5M
Large-scale profiling of microbial and metabolic interactions between C. difficile and gut microbiota using ultrahigh-throughput droplet microfluidicsR21AI159980 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI VENTURELLI, OPHELIA · 2021 to 2022
$428k
Elucidating ecological mechanisms for propagation of antibiotic resistance genes via massively parallelized single-cell sequencingR21AI156438 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI VENTURELLI, OPHELIA · 2021 to 2022
$427k
NIAID NIH HHS R21 AI156438NIAID NIH HHS R21 AI159980NIDDK NIH HHS R01 DK133479NIGMS NIH HHS R35 GM124774
6 · The paper itself

Abstract

Clostridioides difficile can transiently or persistently colonize the human gut, posing a risk for infections. This colonization is influenced by complex molecular and ecological interactions with the human gut microbiota. By investigating C. difficile dynamics in human gut communities over hundreds of generations, we show patterns of stable coexistence, instability, or competitive exclusion. Lowering carbohydrate concentrations shifted a community containing C. difficile and the prevalent human gut symbiont Phocaeicola vulgatus from competitive exclusion to coexistence, facilitated by increased cross-feeding. In this environment, two key mutations in C. difficile altered its metabolic niche from proline to glucose utilization. These metabolic changes in C. difficile substantially impacted gut microbiota inter-species interactions and reduced disease severity in mice. In sum, interactions with P. vulgatus are crucial in shaping the long-term growth dynamics and evolutionary adaptations of C. difficile, offering key insights for developing anti-C. difficile strategies.

Indexed as

Clostridioides difficileClostridium InfectionsGastrointestinal MicrobiomeSymbiosisAdaptation, PhysiologicalAnimalsHumansMiceMutationClostridioides difficilecommunity assemblycomputational modelingcross-feedingevolutionary adaptationshuman gut microbiomeinter-species interactionsPhocaeicola vulgatus

Identifiers

PMID39730002
PMCPMC11852276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.